TY  - BOOK
AU  - Gonzalez-Alvarez, Maria Isabel||Dahan, Arik
TI  - Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation
SN  - 9783040000000
KW  - bioequivalence||Biopharmaceutics Classification System||in vitro||dissolution test||pravastatin||oral absorption||in silico modeling||GastroPlus||Phoenix WinNonlin||pharmacokinetics||clinical studies||ibuprofen||manometry||gastrointestinal||mechanistic modeling||PBPK||PBBM||disintegration||dissolution||enteric-coated||ICH||quality control||regional intestinal permeability||permeation enhancers||absorption-modifying excipients||oral peptide delivery||intestinal perfusion||pharmaceutical development||controlled release drug product||biopharmaceutics classification system||drug solubility||drug permeability||location-dependent absorption||segregated flow intestinal model (SFM)||traditional model (TM)||route-dependent intestinal metabolism||first-pass effect||drug-drug interactions||DDI||in vitro in vivo extrapolations||IVIVE||zero-order absorption||first-order absorption||combined zero- and first-order absorption||transit compartment absorption model||in situ perfusion||microdevices||shape||mucoadhesion||colon absorption||nutrient digestion||nutrient absorption||gastrointestinal hormone||postprandial glycaemia||energy intake||region of the gut||obesity||type 2 diabetes||Franz–PAMPA||BCS drugs||biomimetic membrane||Franz cell||passive drug transport||BCS class IV drugs||segmental-dependent intestinal permeability||intestinal absorption||oral drug delivery||biopharmaceutics||physiologically-based pharmacokinetic (PBPK) modeling||furosemide||intestinal permeability||human colon carcinoma cell layer (Caco-2)||hierarchical support vector regression (HSVR)||drug absorption||drug solubility/dissolution||regional/segmental-dependent permeability and absorption
UR  - https://mdpi.com/books/pdfview/book/5393
ER  -